KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Amortization - Intangibles (2009 - 2012)

Amgen's quarterly Amortization - Intangibles came in at $73.0 million in Q4 2012, little changed year-on-year from $73.0 million in Q1 2012, and down 1.35% quarter-over-quarter from $74.0 million in Q3 2012.

Amgen has reported Amortization - Intangibles for 4 years, with the latest figure at $73.0 million in Q4 2012.

  • For the quarter ending Q4 2012, Amortization - Intangibles changed 0.0% year-over-year to $73.0 million; the trailing twelve-month figure through Dec 2012 stood at $294.0 million (changed 0.0% YoY), and the FY2012 full-year result was $294.0 million, changed 0.0% from the prior year.
  • Amortization - Intangibles for Q4 2012 stood at $73.0 million, down from $74.0 million in the prior quarter.
  • The five-year high for Amortization - Intangibles was $74.0 million in Q1 2009, with the low at $73.0 million in Q2 2009.
  • Average Amortization - Intangibles over 4 years is $73.5 million, with a median of $73.5 million recorded in 2009.
  • Peak annual rise in Amortization - Intangibles reached 0.0% in 2010, while the deepest fall reached 0.0% in 2010.
  • Tracing AMGN's Amortization - Intangibles over 4 years: stood at $73.0 million in 2009, then changed by 0.0% to $73.0 million in 2010, then changed by 0.0% to $73.0 million in 2011, then changed by 0.0% to $73.0 million in 2012.
  • The last three Amortization - Intangibles figures came in at $73.0 million (Q4 2012), $74.0 million (Q3 2012), and $73.0 million (Q2 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 73.00 Mn
Sep 30, 2012 74.00 Mn
Jun 30, 2012 73.00 Mn
Mar 31, 2012 74.00 Mn
Dec 31, 2011 73.00 Mn
Sep 30, 2011 74.00 Mn
Jun 30, 2011 73.00 Mn
Mar 31, 2011 74.00 Mn
Dec 31, 2010 73.00 Mn
Sep 30, 2010 74.00 Mn
Jun 30, 2010 73.00 Mn
Mar 31, 2010 74.00 Mn
Dec 31, 2009 73.00 Mn
Sep 30, 2009 74.00 Mn
Jun 30, 2009 73.00 Mn
Mar 31, 2009 74.00 Mn